相似文献
1
Phospholipid derived mediators and glomerulonephritis.
Mediators Inflamm. 1993;2(2):99-102. doi: 10.1155/S0962935193000134.
2
Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Crit Care Med. 1999 Nov;27(11):2485-94. doi: 10.1097/00003246-199911000-00027.
3
Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock.
Crit Care Med. 1995 Feb;23(2):231-7. doi: 10.1097/00003246-199502000-00006.
4
Leukotrienes and lipoxins: lipoxygenase-derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis.
Nephrol Dial Transplant. 1998 Dec;13(12):3043-51. doi: 10.1093/ndt/13.12.3043.
5
Urinary eicosanoids and the assessment of glomerular inflammation.
J Am Soc Nephrol. 1992 May;2(11):1560-7. doi: 10.1681/ASN.V2111560.
6
Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma.
Ann Allergy Asthma Immunol. 1998 Mar;80(3):245-50. doi: 10.1016/S1081-1206(10)62965-1.
7
Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
J Lab Clin Med. 1999 Nov;134(5):478-82. doi: 10.1016/s0022-2143(99)90169-5.
8
Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells.
Biochem Pharmacol. 2016 Feb 15;102:78-96. doi: 10.1016/j.bcp.2015.12.001. Epub 2015 Dec 7.
9
Platelet-activating factor mediates trinitrobenzene induced colitis.
Prostaglandins Leukot Essent Fatty Acids. 1994 Dec;51(6):419-24. doi: 10.1016/0952-3278(94)90059-0.
10
Pharmacology of thromboxane A2, prostacyclin and other eicosanoids in the cardiovascular system.
Therapie. 1991 May-Jun;46(3):217-21.
本文引用的文献
1
Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis.
Kidney Int. 1993 Feb;43(2):426-9. doi: 10.1038/ki.1993.62.
2
Nonimmunological production of leukotrienes induced by platelet-activating factor.
Science. 1982 Oct 15;218(4569):286-9. doi: 10.1126/science.7123233.
3
Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
J Clin Invest. 1983 Oct;72(4):1439-48. doi: 10.1172/JCI111100.
4
Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
J Clin Invest. 1985 Jan;75(1):94-101. doi: 10.1172/JCI111703.
5
Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
J Pharmacol Exp Ther. 1985 Jun;233(3):672-8.
6
Effects of leukotriene D4 on glomerular dynamics in the rat.
Am J Physiol. 1987 Aug;253(2 Pt 2):F239-43. doi: 10.1152/ajprenal.1987.253.2.F239.
7
The action of lipoxin-A on glomerular microcirculatory dynamics in the rat.
Biochem Biophys Res Commun. 1987 May 29;145(1):408-14. doi: 10.1016/0006-291x(87)91337-4.
8
Potential role of platelet-activating factor in renal pathophysiology.
Kidney Int. 1986 Feb;29(2):469-77. doi: 10.1038/ki.1986.23.
9
Leukotriene C4 and D4 contract rat glomerular mesangial cells.
Kidney Int. 1986 Oct;30(4):524-31. doi: 10.1038/ki.1986.217.
10
Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites.
Gastroenterology. 1988 Oct;95(4):1081-7. doi: 10.1016/0016-5085(88)90186-2.
Zotero 插件